MHR
Matthew Hamilton Rosenberg’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $722K | Buy |
3,889
+450
| +13% | +$83.5K | 0.17% | 58 |
|
|
2025
Q1 | $721K | Buy |
3,439
+278
| +9% | +$58.3K | 0.18% | 55 |
|
|
2024
Q4 | $562K | Buy |
3,161
+174
| +6% | +$30.9K | 0.15% | 67 |
|
|
2024
Q3 | $590K | Buy |
2,987
+37
| +1% | +$7.31K | 0.15% | 69 |
|
|
2024
Q2 | $503K | Sell |
2,950
-455
| -13% | -$77.5K | 0.15% | 71 |
|
|
2024
Q1 | $615K | Buy |
3,405
+30
| +0.9% | +$5.42K | 0.18% | 61 |
|
|
2023
Q4 | $523K | Buy |
3,375
+81
| +2% | +$12.6K | 0.16% | 66 |
|
|
2023
Q3 | $491K | Sell |
3,294
-88
| -3% | -$13.1K | 0.16% | 63 |
|
|
2023
Q2 | $456K | Sell |
3,382
-749
| -18% | -$101K | 0.15% | 69 |
|
|
2023
Q1 | $658K | Sell |
4,131
-92
| -2% | -$14.7K | 0.21% | 56 |
|
|
2022
Q4 | $683K | Buy |
4,223
+100
| +2% | +$16.2K | 0.23% | 55 |
|
|
2022
Q3 | $553K | Buy |
4,123
+240
| +6% | +$32.2K | 0.21% | 58 |
|
|
2022
Q2 | $597K | Buy |
3,883
+301
| +8% | +$46.3K | 0.23% | 61 |
|
|
2022
Q1 | $581K | Buy |
3,582
+261
| +8% | +$42.3K | 0.2% | 63 |
|
|
2021
Q4 | $450K | Buy |
3,321
+250
| +8% | +$33.9K | 0.16% | 73 |
|
|
2021
Q3 | $331K | Buy |
3,071
+787
| +34% | +$84.8K | 0.13% | 99 |
|
|
2021
Q2 | $257K | Hold |
2,284
| – | – | 0.13% | 99 |
|
|
2021
Q1 | $247K | Hold |
2,284
| – | – | 0.14% | 94 |
|
|
2020
Q4 | $245K | Sell |
2,284
-93
| -4% | -$9.98K | 0.15% | 82 |
|
|
2020
Q3 | $208K | Hold |
2,377
| – | – | 0.15% | 86 |
|
|
2020
Q2 | $233K | Buy |
2,377
+547
| +30% | +$53.6K | 0.19% | 70 |
|
|
2020
Q1 | $140K | Buy |
+1,830
| New | +$140K | 0.14% | 86 |
|